If India is serious about rooting out fraud it needs to provide strong protection to whistleblowers and incentivise them for risks. In its current form, the proposed Indian law places the onus on the whistleblower not only to report the fraud, but also to prove their integrity. The government should welcome whistleblowers, be their advocate, and use their unique status as insiders to guarantee the integrity of our social programmes.

FCA | Dinesh Thakur, Ranbaxy, Incentived Integrity

The process of globalization compresses and shapes every facet of the modern world: economic, political, technological, and social.  

The law is not exempt. 

FCA | SEC Whistleblower Office, false claims act, Ranbaxy, Department of Justice, Department of Defense

Ranbaxy has reserved $40 million to settle a Texas False Claims Act case alleging Medicaid best price violations. A bigger national case may be coming. Ranbaxy was nailed for $500 million under the FCA in 2013, and pled guilty to numerous felony charges.


State FCA | Ranbaxy, Dinesh Thakur, best price, Medicaid, Texas

Dinesh Thakur wins the Joe A. Calloway Award for Civic Courage from the Shafeek Nader Trust.

| Dinesh Thakur, Ranbaxy